Irinotecan HCL 3H2O / Irinotecan Hydrochloride Trihydrate Powder Used As Drugs
Product details:
Product Name : Irinotecan Hydrochloride
CAS No.: 100286-90-6
Other Names:Irinotecan hcl
Sample :Available
Shelf times:2 years
Appearance:white to whitish crystal powder
Melting Point : Purity 99% MIn
Water: 7.0%-9.0%
PH: 3.5-5.0
Structure :
Key Words:
API; an antineoplastic; treat colon cancer, and small cell lung cancer; given by slow injection into a vein
Irinotecan hydrochloride trihydrate, CAS 136572-09-3,
Irinotecan hydrochloride trihydrate, CAS 136572-09-3 supplier,
Irinotecan hydrochloride trihydrate, CAS 136572-09-3 distributor,
CAS 136572-09-3
Irinotecan hydrochloride trihydrate, CAS 136572-09-3 manufacturer,
Irinotecan hydrochloride trihydrate, CAS 136572-09-3 wholesale;
China Irinotecan hydrochloride trihydrate, CAS 136572-09-3 manufacturers;
Irinotecan hydrochloride trihydrate, CAS 136572-09-3 cost,
Irinotecan hydrochloride trihydrate, CAS 136572-09-3 buy,
Irinotecan hydrochloride trihydrate, CAS 136572-09-3 sale
Function :
For the treatment of metastatic colorectal cancer (first-line therapy when administered with 5-fluorouracil and leucovorin). Also used in combination with cisplatin for the treatment of extensive small cell lung cancer. Irinotecan is currently under investigation for the treatment of metastatic or recurrent cervical cancer. Also used in combination with fluorouracil and leucovorin for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.
Specification :
Irinotecan hydrochloride Current USP
Appearance |
Pale yellow to yellow crystalline powder |
Conforms |
Specific rotation |
+61.0°- +69.0° |
+64.4° |
PH |
3.5-5.0 |
4.8 |
Water |
7.0%-9.0% |
8.40% |
Heavy metals |
≤ 10ppm |
Conforms |
Residue on ignition |
≤ 0.1% |
0.08% |
Assay(on dry basis) |
98.5%-101.5% |
99.30% |
Application :
It is Mainly applied in Pharmaceutical, Medicinal Field.